Which are the causes of Lambert-Eaton myasthenic syndrome?

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder where the body's immune system mistakenly attacks the connection between nerves and muscles, specifically targeting voltage-gated calcium channels. Approximately 50% to 60% of cases are associated with an underlying malignancy, most commonly small-cell lung cancer, while the remaining cases are considered primary autoimmune in nature.

What is the underlying mechanism of Lambert-Eaton myasthenic syndrome?

To understand Lambert-Eaton myasthenic syndrome, imagine your nerves as a sender and your muscles as a receiver. For a muscle to contract, the nerve must release a chemical messenger called acetylcholine. This release is triggered by calcium entering the nerve terminal through specific "gates" called voltage-gated calcium channels (VGCCs). In Lambert-Eaton myasthenic syndrome, the immune system produces antibodies that attack these VGCCs. When these channels are blocked or destroyed, the nerve cannot release enough acetylcholine to trigger a strong muscle contraction, leading to the characteristic muscle weakness and fatigue seen in patients.

Is Lambert-Eaton myasthenic syndrome caused by cancer?

There is a strong, well-documented link between Lambert-Eaton myasthenic syndrome and small-cell lung cancer (SCLC). This is known as paraneoplastic LEMS. In these cases, the cancer cells express proteins that resemble the calcium channels on nerve endings. The immune system, in its attempt to fight the tumor, accidentally creates antibodies that cross-react and attack the body’s healthy nerve-muscle junctions. While not all patients have cancer, it is critical for those diagnosed with Lambert-Eaton myasthenic syndrome to undergo thorough screening for underlying malignancies, particularly if they have a history of smoking.

Does genetics play a role in Lambert-Eaton myasthenic syndrome?

Unlike some other neurological conditions, Lambert-Eaton myasthenic syndrome is not considered a hereditary genetic disease. There is no single gene mutation that causes the disorder. However, research suggests that certain human leukocyte antigen (HLA) types—which are genetic markers that help regulate the immune system—may predispose an individual to developing autoimmune conditions, including Lambert-Eaton myasthenic syndrome. This means genetics may influence your susceptibility to an autoimmune trigger, but they do not directly "cause" the disease in the way a mutation causes cystic fibrosis.

What are the primary triggers and risk factors?

Distinguishing between a cause and a risk factor is helpful for understanding your health journey. A cause is the direct biological mechanism (the antibodies attacking the VGCCs), while risk factors increase the likelihood of the immune system becoming misdirected. Current research into Lambert-Eaton myasthenic syndrome highlights the following risk factors:

• Small-cell lung cancer: Present in about 50–60% of cases; identifying this is a top priority for clinical teams.


• Autoimmune predisposition: A personal or family history of other autoimmune disorders, such as thyroid disease or type 1 diabetes.


• Smoking history: Strongly correlated with the tumor-associated form of the disease.


• Age of onset: While it can occur at any age, the tumor-associated form is most common in individuals over age 50.

What is the current state of research into the etiology?

Medical researchers are currently working to better understand why the immune system "toggles" into this destructive state. While we know the target (the P/Q-type voltage-gated calcium channels), ongoing studies are investigating the molecular triggers that initiate antibody production in the non-tumor form of the disease. Researchers are also looking for more sensitive biomarkers that could predict the disease course or the presence of an occult (hidden) tumor earlier than current imaging allows.

Next steps

• Consult with a neurologist specializing in neuromuscular disorders to confirm your diagnosis via electrodiagnostic testing and antibody blood panels.


• Discuss age-appropriate cancer screenings with your physician, even if you do not have symptoms of a tumor.


• Join the Lambert-Eaton myasthenic syndrome community at DiseaseMaps.org to connect with the 23 members who have shared their experiences and treatment insights.


• Keep a symptom journal to track how your muscle strength fluctuates, which can assist your medical team in adjusting your treatment plan.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institute of Neurological Disorders and Stroke (NINDS) / NIH GARD: Lambert-Eaton Myasthenic Syndrome.


• Orphanet: Lambert-Eaton myasthenic syndrome (ORPHA:539).


• OMIM (Online Mendelian Inheritance in Man): Entry regarding autoimmune neuromuscular junction disorders.


• Myasthenia Gravis Foundation of America (MGFA): Resources and clinical guidelines for LEMS.